Skip to main content
Clinical Trials/NCT02327026
NCT02327026
Completed
Not Applicable

Initial Airway Management in Patients With Out-of-Hospital Cardiac Arrest: Tracheal Intubation vs. Bag-valve-mask Ventilation - CAAM STUDY

Assistance Publique - Hôpitaux de Paris1 site in 1 country2,043 target enrollmentMarch 9, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Out-of-hospital Cardiac Arrest
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
2043
Locations
1
Primary Endpoint
Survival with favorable neurological function defined as Glasgow-Pittsburgh Cerebral Performance Categories (CPC) of 2 or less.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The aim of this study is to improve the management of patients in cardiac arrest, and this by comparing two initial airway management methods: Tracheal intubation and bag-valve-mask ventilation.

The survival rate at 28-day with favorable neurological function will be compared in the tracheal intubation group versus the bag-valve-mask group

Detailed Description

It is a multicenter prospective non-inferiority open randomized controlled trial in patients with out-of-hospital cardiac arrest carried out in physician-staffed emergency medical services. The investigators hypothesis is that basic airway management (i.e. bag-valve-mask ventilation) is safe and may avoid the deleterious effects of tracheal intubation including interruption of chest compressions. On medical team's arrival at the scene and after verification of participant's eligibility, patients will be enrolled in the study and randomly assigned to either initial bag-valve-mask ventilation or tracheal intubation. After the hospital admission, all patients will be intubated whatever the initial airway management.

Registry
clinicaltrials.gov
Start Date
March 9, 2015
End Date
March 30, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older;
  • Patient with out-of-hospital cardiac arrest on medical team's arrival
  • Resuscitation attempted
  • Medical insurance

Exclusion Criteria

  • Massive suspected aspiration
  • Presence of do-not-resuscitate order
  • Pregnancy
  • Prisoners

Outcomes

Primary Outcomes

Survival with favorable neurological function defined as Glasgow-Pittsburgh Cerebral Performance Categories (CPC) of 2 or less.

Time Frame: Day 28

Survival at 28-day with favorable neurological function defined as Glasgow-Pittsburgh Cerebral Performance Categories (CPC) of 2 or less. In case of neurological disability before randomization, the survival associated the same degree of disability will be considered a favorable neurological function

Secondary Outcomes

  • Survival at hospital discharge(up to Day 28)
  • Neurologic outcomes assessed by modified Rankin scale score(Day 28)
  • Ventilation difficulty with bag-valve-mask measured with a visual-analog-scale (VAS)(Day 0)
  • Technique's failure defined as mortality(Day 0, Day 28)
  • Han's mask ventilation classification(Day 0)
  • Rate of return of spontaneous circulation (ROSC)(Day 0)
  • Complications related to tracheal intubation(Day 0)
  • Survival(Day 28)
  • Survival at hospital admission(Day 0)
  • Intubation difficulty assessed by Intubation difficulty Scale score(Day 0)
  • Complications related to bag-valve-mask ventilation(Day 0)
  • Difficult mask ventilation signs(Day 0)
  • Duration of the interruption of chest compression during TI procedure(Day 0)
  • Time to completion of tracheal intubation (TI) procedure(Day 0)
  • Duration of the interruption of chest compression during advanced CPR (from medical team's arrival to decision to stop CPR)(Day 0)
  • Duration of advanced CPR(Day 0)

Study Sites (1)

Loading locations...

Similar Trials